Microbiology Graduate Group, University of California at Davis, Davis, CA, USA.
Antimicrob Agents Chemother. 2010 Sep;54(9):4000-2. doi: 10.1128/AAC.01754-09. Epub 2010 Jun 14.
Highly pathogenic Yersinia enterocolitica biovar 1B produces two distinct beta-lactamases, BlaA and BlaB. Mutants of a representative biovar 1B isolate were constructed and evaluated to determine the extent of limitation of susceptibility to broad-spectrum beta-lactam antibiotics by BlaA and BlaB. The results demonstrated that BlaA, a class A enzyme, plays a significant role in limiting susceptibility to penicillins and cephalosporins. The contribution of BlaB, a class C enzyme, was less profound and was limited primarily to cephalosporin susceptibility.
高致病性小肠结肠炎耶尔森菌生物型 1B 产生两种不同的β-内酰胺酶,BlaA 和 BlaB。构建并评估了代表性生物型 1B 分离株的突变体,以确定 BlaA 和 BlaB 对广谱β-内酰胺类抗生素敏感性的限制程度。结果表明,BlaA 为 A 类酶,在限制青霉素和头孢菌素的敏感性方面发挥重要作用。BlaB 的作用(C 类酶)则不那么显著,主要局限于头孢菌素的敏感性。